NBM Pharmaceuticals Private Limited

NBM Pharmaceuticals Private Limited - pharma in Jodhpur, Rajasthan, India. FY 2026 financials & compliance.
CIN U24100RJ2020PTC070609 Incorporated 28 August 2020 ROC Jaipur HQ Jodhpur, Rajasthan, India
Active Private Limited Company pharma MSME · Micro
Data last updated
Revenue · FY 2025
₹94.22 Lakh
▲ 37% YoY
Net profit · FY 2025
₹22,714
Net margin 0.2%
EBITDA · FY 2025
₹51,359
EBITDA margin 0.5%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
6 yrs
Est. 2020
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered

About NBM Pharmaceuticals Private Limited

Data last updated:

NBM Pharmaceuticals Private Limited is a private limited company based in Jodhpur, Rajasthan, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 28 August 2020 and has been in existence for over 6 years.

The company is registered with the Registrar of Companies (ROC), Jaipur, under CIN U24100RJ2020PTC070609. Its GSTIN is 08AAHCN1247Q1ZY (Rajasthan).

The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Ram Swaroop Bishnoi and Prashant Bishnoi.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at N 1643 Pn 38 Virender Nagar, Jodhpur, Rajasthan, India – 342007.

As per the financials filed for FY 2025, the company reported a revenue of ₹94.22 Lakh, a growth of 37% compared to the previous year. For the same year it recorded a net profit of ₹22,714 (net margin 0.2%) and EBITDA of ₹51,359 (EBITDA margin 0.5%).

NBM Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-RJ-22-0035087).

Company details

CIN U24100RJ2020PTC070609
Registration Number 070609
Incorporation Date 28 August 2020
ROC Jaipur
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Micro
Udyam Registration UDYAM-RJ-22-0035087

Recognitions & Rankings of NBM Pharmaceuticals

MSME (Udyam registered) Ministry of MSME
Category
Micro (2023-24)
Udyam number
UDYAM-RJ-22-0035087

Contact details

NBM Pharmaceuticals Private Limited's registered office is in Jodhpur, Rajasthan. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    N 1643 Pn 38 Virender Nagar, Jodhpur, Rajasthan, India – 342007
  • Industry
    Pharma, Pharmaceutical Retailers & Distributors

To see the full contact details of NBM Pharmaceuticals Private Limited, buy the company report.

Comprehensive company report
NBM Pharmaceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of NBM Pharmaceuticals is trade. In detail, this covers retail trading.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
GTradeG2Retail Trading

To see the full business activity and turnover split of NBM Pharmaceuticals Private Limited, buy the company report.

Financials of NBM Pharmaceuticals Private Limited

FY 2025 filings available

NBM Pharmaceuticals Private Limited reported revenue of ₹94.22 Lakh (up 37% YoY) for FY 2025.

Revenue · FY 2025
₹94.22 Lakh ▲ 37%
Net profit · FY 2025
₹22,714 margin 0.2%
EBITDA · FY 2025
₹51,359 margin 0.5%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 37%
EBITDA CAGR growth
1 year
▼ 55%
3 years · compounded
▲ 159%

Revenue rose 37% in the latest year. EBITDA fell 55% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹51,359
Profit Before Tax
Tax Expense
Net Profit (PAT)₹22,714
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin0.5%
Net Profit Margin0.2%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of NBM Pharmaceuticals Private Limited, buy the company report.

Board of directors of NBM Pharmaceuticals Private Limited

NBM Pharmaceuticals has 2 directors on record. No former directors are listed.

Current Directors
NameDesignationAppointment DateTenureStatus
Ram Swaroop BishnoiDirector28 Aug 20206 Years 1 MonthsCurrent
Prashant BishnoiDirector28 Aug 20206 Years 1 MonthsCurrent

Peer comparison

NBM Pharmaceuticals Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (retail trading), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Trivet Pharmaceuticals Private Limited₹94.96 Lakh (FY 2024)-7.0%Karnal, Haryana, India
Orbit Chem Pharmaceuticals Private Limited₹94.95 Lakh (FY 2024)-51.0%Cherapalli, Telangana, India
NBM Pharmaceuticals Private Limitedthis company₹94.22 Lakh (FY 2025)₹22,7140.2%37.0%Jodhpur, Rajasthan, India
Gifs Plus Pharmaceuticals Private Limited₹93.7 Lakh (FY 2025)-3.0%Washim, Maharashtra, India

To see the full peer comparison of NBM Pharmaceuticals Private Limited, buy the company report.

Auditor

NBM Pharmaceuticals Private Limited is audited by RATHI PANKAJ & ASSOCIATES for the financial year 2023.

Auditor firmFinancial yearFirm registration number
RATHI PANKAJ & ASSOCIATESFY 2023417084

Shareholding

The shareholding of NBM Pharmaceuticals Private Limited is on record for 3 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2023FY 2022FY 2021
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of NBM Pharmaceuticals Private Limited, buy the company report.

MSME payment delays

No delayed payments to MSME suppliers are on our record for NBM Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

Employees & EPFO

NBM Pharmaceuticals Private Limited has 1 active EPFO establishment as of Apr 05, 2024.

Active EPFO establishments
1

GST

NBM Pharmaceuticals has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
08AAHCN1247Q1ZYRajasthanActive14 Mar 2023

To see the full GST registrations and return filing status of NBM Pharmaceuticals Private Limited, buy the company report.

Recent activity

NBM Pharmaceuticals Private Limited has 2 board changes on record since 2020: 2 appointments. The latest: Prashant Bishnoi was appointed as Director on 28 Aug 2020.

AGM
Nbm Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Nbm Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Jaipur.
Appointed
Prashant Bishnoi was appointed as Director.
Appointed
Ram Swaroop Bishnoi was appointed as Director.
Incorporation
28 Aug 2020
Nbm Pharmaceuticals Private Limited was registered on 28 Aug 2020 with Roc Jaipur & aged 6 years 1 month as per MCA records.

Frequently asked questions

NBM Pharmaceuticals is an active private limited company based in Jodhpur, Rajasthan, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 28 August 2020 (6+ years old) and is registered under CIN U24100RJ2020PTC070609.

NBM Pharmaceuticals has 2 current directors:

The latest financial statements of NBM Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.

The GSTIN of NBM Pharmaceuticals is 08AAHCN1247Q1ZY, registered in Rajasthan.

The CIN (Corporate Identification Number) of NBM Pharmaceuticals is U24100RJ2020PTC070609. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

NBM Pharmaceuticals was incorporated on 28 August 2020, making it 6+ years old. It is registered with the Registrar of Companies, Jaipur.

The peers of NBM Pharmaceuticals by revenue are Trivet Pharmaceuticals Private Limited, Orbit Chem Pharmaceuticals Private Limited, Gifs Plus Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (retail trading).

Prashant Bishnoi was appointed as Director on 28 Aug 2020. Ram Swaroop Bishnoi was appointed as Director on 28 Aug 2020.

Yes, NBM Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-RJ-22-0035087).

The registered office of NBM Pharmaceuticals is at N 1643 Pn 38 Virender Nagar, Jodhpur, Rajasthan, India – 342007.

NBM Pharmaceuticals operates in the pharma industry, in the pharmaceutical retailers and distributors segment.